SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-phase trial tests whether a fluorescent dye attached to an immunotherapy drug can help surgeons see head and neck cancer cells during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The main goal is to check if the…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
New study aims to predict cancer treatment success with scans and DNA
Knowledge-focused Not yet recruitingThis study looks at whether combining medical scans (CT, MRI, PET) with tumor DNA tests can better predict how head and neck cancer responds to chemoradiotherapy. About 152 adults with certain stages of oropharynx or oral cavity cancer will be followed for 12 months after treatme…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC